1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Subgroup analysis of older patients treated within the randomized phase 3 doxorubicin versus doxorubicin plus evofosfamide (SARC021) trial
    Journal Article

    Younger, E.; Ballman, K.; Lu, Y.; Pápai, Z.; Van Tine, B. A.; Attia, S.; Schöffski, P.; Reinke, D.; Tap, W. D.; Jones, R. L.
    Journal of Geriatric Oncology (2020)

    Fulltext@MSK | Save
  • Personalized management of chemotherapy-induced peripheral neuropathy based on a patient reported outcome: CALGB 40502 (Alliance)
    Journal Article

    Sharma, M. R.; Mehrotra, S.; Gray, E.; Wu, K.; Barry, W. T.; Hudis, C.; Winer, E. P.; Lyss, A. P.; Toppmeyer, D. L.; Moreno-Aspitia, A.; more...
    Journal of Clinical Pharmacology (2020)

    Fulltext@MSK | Save
  • Assessment of adverse events from the patient perspective in a phase 3 metastatic castration-resistant prostate cancer clinical trial
    Journal Article

    Dueck, A. C.; Scher, H. I.; Bennett, A. V.; Mazza, G. L.; Thanarajasingam, G.; Schwab, G.; Weitzman, A. L.; Rogak, L. J.; Basch, E.
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Association between new unconfirmed bone lesions and outcomes in men with metastatic castration-resistant prostate cancer treated with enzalutamide: Secondary analysis of the PREVAIL and AFFIRM randomized clinical trials
    Journal Article

    Armstrong, A. J.; Al-Adhami, M.; Lin, P.; Parli, T.; Sugg, J.; Steinberg, J.; Tombal, B.; Sternberg, C. N.; De Bono, J.; Scher, H. I.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Efficacy of nivolumab plus ipilimumab according to number of IMDC risk factors in CheckMate 214
    Journal Article

    Escudier, B.; Motzer, R. J.; Tannir, N. M.; Porta, C.; Tomita, Y.; Maurer, M. A.; McHenry, M. B.; Rini, B. I.
    European Urology (2020)

    Fulltext@MSK | Save
  • A prospective randomized comparative study of three guided bronchoscopic approaches for investigating pulmonary nodules: The PRECISION-1 study
    Journal Article

    Yarmus, L.; Akulian, J.; Wahidi, M.; Chen, A.; Steltz, J. P.; Solomon, S. L.; Yu, D.; Maldonado, F.; Cardenas-Garcia, J.; Molena, D.; more...
    Chest (2020)

    Fulltext@MSK | Save
  • Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101
    Journal Article

    Uemura, M.; Tomita, Y.; Miyake, H.; Hatakeyama, S.; Kanayama, H. O.; Numakura, K.; Takagi, T.; Kato, T.; Eto, M.; Obara, W.; more...
    Cancer Science (2020)

    Fulltext@MSK | Save
  • Results of the NRG Oncology/RTOG 0848 adjuvant chemotherapy question - Erlotinib+gemcitabine for resected cancer of the pancreatic head: A phase II randomized clinical trial
    Journal Article

    Abrams, R. A.; Winter, K. A.; Safran, H.; Goodman, K. A.; Regine, W. F.; Berger, A. C.; Gillin, M. T.; Philip, P. A.; Lowy, A. M.; Wu, A.; more...
    American Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Comparison of abbreviated breast MRI vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening
    Journal Article

    Comstock, C. E.; Gatsonis, C.; Newstead, G. M.; Snyder, B. S.; Gareen, I. F.; Bergin, J. T.; Rahbar, H.; Sung, J. S.; Jacobs, C.; Harvey, J. A.; more...
    JAMA - Journal of the American Medical Association (2020)

    Fulltext@MSK | Save
  • Guidelines for time-to-event end-point definitions in adjuvant randomised trials for patients with localised colon cancer: Results of the DATECAN initiative
    Guidelines

    Cohen, R.; Vernerey, D.; Bellera, C.; Meurisse, A.; Henriques, J.; Paoletti, X.; Rousseau, B.; Alberts, S.; Aparicio, T.; Boukovinas, I.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save